Gold Skin Care Center
Gold Skin Care Center was paid $2.07M by Medicaid between Jan 2018 and Dec 2024, across 25 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.
33Billing provider infoGOLD SKIN CARE CENTER
NASHVILLE, TN 37215
NASHVILLE, TN 37215
33aNPI1336121821assigned 11/18/2005
33bProvider typeSpecialist
28Total paid$2.07M
24GClaims106,572
24DCodes billed25
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Tennessee
Rank by total paid#15 of 252
Median peer was paid$57K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,509 | $155K | |
| 2019 | 12,435 | $232K | |
| 2020 | 11,702 | $183K | |
| 2021 | 21,124 | $391K | |
| 2022 | 19,593 | $385K | |
| 2023 | 19,632 | $417K | |
| 2024incomplete | 14,577 | $306K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 12,093 | 10,515 | $378K |
| 11900 | 16% | 15,644 | 11,297 | $334K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 11% | 14,677 | 11,418 | $234K |
| 17340 | 10% | 7,315 | 5,698 | $216K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.6% | 2,533 | 2,345 | $137K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.0% | 2,192 | 1,749 | $124K |
| 17110 | 5.9% | 2,652 | 2,107 | $122K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5.4% | 10,060 | 7,181 | $111K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.3% | 2,456 | 2,081 | $110K |
| 11901 | 5.2% | 3,492 | 2,666 | $108K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.6% | 874 | 824 | $75K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 2.2% | 25,006 | 17,855 | $45K |
13 more codes
| 11300 | 1.3% | 1,433 | $27K | |
| 96401 | <1% | 440 | $12K | |
| 11301 | <1% | 332 | $9K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 221 | $8K |
| 11310 | <1% | 301 | $7K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,770 | $4K |
| 10040 | <1% | 53 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,663 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 214 | $412.56 |
| 0011A | <1% | 14 | $320.00 | |
| 11100 | <1% | 16 | $194.14 | |
| 91301 | 0% | 40 | $0.00 | |
| 99024 | 0% | 81 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOLD, MICHAEL (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Oklahoma Sleep Institute Clinic Okc LLC Osi Clinic | Oklahoma City, OK | $75K |
| Geronnursing & Respite Care, INC. | New Milford, CT | $71K |
| Big Y Foods, INC. | Danielson, CT | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.